Axsome Therapeutics Inc
UnclaimedPharmaceutical Preparation ManufacturingNew York, NY
Founded
2012
Primary NAICS
325412
CAGE code
7J7H1
Federal awards
—
Overview
We are committed to developing products that meaningfully improve the lives of patients. Axsome is developing innovative treatments including AXS-05, AXS-12, and AXS‑14. learn about our pipeline Axsome focuses on CNS conditions including depression, Alzheimer's disease agitation, migraine, narcolepsy and fibromyalgia. learn about these CNS conditions & more AXS-05 AXS-12 AXS-14 recent news Please see full Prescribing Information, […]
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- Pharmaceutical Preparation Manufacturing325412
Capabilities
Federal awards
| Year | Agency | Obligated | Actions |
|---|---|---|---|
| 2026 | Department of Veterans Affairs | $0 | 8 |
| 2025 | Department of Veterans Affairs | $0 | 6 |
| 2024 | Department of Veterans Affairs | $0 | 3 |
| 2023 | Department of Veterans Affairs | $0 | 5 |
| 2022 | Department of Veterans Affairs | $0 | 1 |